Glukoza Braun

Glukoza Braun is an intravenous solution that contains glucose monohydrate as its active ingredient. It is supplied as a sterile liquid for parenteral use, typically in a concentration suitable for fluid replacement and energy provision. The product is marketed in the European Union and is classified as an excipient used in parenteral nutrition and hypoglycemia management.

Glukoza Braun is employed in clinical settings where rapid glucose supplementation or fluid balance is required. It is commonly used for: - Treatment of hypoglycemia in patients unable to take oral glucose. - Providing caloric support as part of parenteral nutrition regimens. - Maintaining fluid and electrolyte balance during surgery or critical illness. - Diluting or reconstituting other intravenous medications when a glucose carrier is needed. - Supporting patients with prolonged fasting or severe malnutrition.

Glukoza Braun may cause a range of reactions, most of which are related to its glucose content and intravenous administration.

Common: - Transient hyperglycemia or elevated blood glucose levels. - Local irritation at the infusion site. - Mild nausea or abdominal discomfort. - Fluid overload in patients with compromised cardiac function.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Allergic reaction such as rash, pruritus, or anaphylaxis. - Electrolyte imbalance, particularly hyponatremia. - Venous thrombosis or phlebitis at the catheter site.

When using Glukoza Braun, clinicians should consider several safety factors to minimize risk. Important precautions include: - Assess baseline blood glucose and monitor levels frequently during infusion. - Evaluate cardiac and renal function to avoid fluid overload. - Use aseptic technique to prevent catheter‑related infections. - Adjust infusion rate in patients with diabetes or insulin therapy. - Review electrolyte status, especially sodium and potassium, before and during treatment. - Consider alternative carbohydrate sources if the patient has a known glucose intolerance.

Glukoza Braun can interact with other medications or clinical conditions, requiring careful management.

Avoid: - Co‑administration with high‑dose insulin without glucose monitoring, which may precipitate severe hypoglycemia. - Simultaneous infusion of potassium chloride in concentrations that could cause hyperkalemia.

Use with caution: - Concurrent use of diuretics that may alter fluid balance. - Administration alongside other hyperosmolar solutions, which can increase the risk of osmotic injury. - Patients receiving corticosteroids, as they may exacerbate hyperglycemia. - Situations where rapid electrolyte shifts are expected, such as during massive transfusion.